Tuberculosis (TB) surpassed HIV/AIDS in 2015 to become the greatest infectious disease killer on the planet, while the inexorable rise of drug-resistant TB adds another layer of complexity to TB control challenges in both high and low incidence settings. The advances in molecular genotyping of Mycobacterium tuberculosis has promised new but yet validated evidence and performance indicators to inform jurisdictional TB control programs. The overall aim of this thesis was to improve our understanding of the epidemiology of M. tuberculosis through integration of traditional genotyping and geospatial methods in low and high incidence settings, exemplified, respectively, by New South Wales (NSW), Australia, and Mongolia. It also explored the add...
Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, howeve...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) has become a major public health probl...
Tuberculosis (TB) is an ancient disease, whose control is continuously challenged by emerging threat...
Tuberculosis (TB) has re-emerged over the past two decades: in industrialized countries in associati...
Australia has a low tuberculosis incidence rate with most cases occurring among recent immigrants. G...
Tuberculosis (TB) is a major cause of global mortalities causing 1.6 million deaths in 2017 alone du...
The transcontinental spread of multidrug-resistant (MDR) tuberculosis is poorly characterized in mol...
Background: While the international spread of multidrug-resistant (MDR) Mycobacterium tuberculosis s...
Aims and objectivesThe transmission pattern of drug resistant Mycobacterium tuberculosis (MTB) might...
The transcontinental spread of multidrug-resistant (MDR) tuberculosis is poorly characterized in mol...
ObjectivesCompare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinc...
BACKGROUND: The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycob...
ObjectivesCompare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinc...
The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycobacterium tub...
Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, howeve...
Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, howeve...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) has become a major public health probl...
Tuberculosis (TB) is an ancient disease, whose control is continuously challenged by emerging threat...
Tuberculosis (TB) has re-emerged over the past two decades: in industrialized countries in associati...
Australia has a low tuberculosis incidence rate with most cases occurring among recent immigrants. G...
Tuberculosis (TB) is a major cause of global mortalities causing 1.6 million deaths in 2017 alone du...
The transcontinental spread of multidrug-resistant (MDR) tuberculosis is poorly characterized in mol...
Background: While the international spread of multidrug-resistant (MDR) Mycobacterium tuberculosis s...
Aims and objectivesThe transmission pattern of drug resistant Mycobacterium tuberculosis (MTB) might...
The transcontinental spread of multidrug-resistant (MDR) tuberculosis is poorly characterized in mol...
ObjectivesCompare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinc...
BACKGROUND: The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycob...
ObjectivesCompare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinc...
The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycobacterium tub...
Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, howeve...
Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, howeve...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) has become a major public health probl...
Tuberculosis (TB) is an ancient disease, whose control is continuously challenged by emerging threat...